Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oglemilast in stable mild to moderate persistent asthma
NCT00859404Phase 2Unknown
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Oct 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oglemilast in asthma, sponsored by Glenmark Pharmaceuticals. Status: unknown.
02
Drugs
oglemilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00859404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859404.